LMR Partners LLP Invests $2.56 Million in Encompass Health Co. (NYSE:EHC)

LMR Partners LLP purchased a new stake in Encompass Health Co. (NYSE:EHC - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 27,760 shares of the company's stock, valued at approximately $2,564,000.

Several other large investors have also made changes to their positions in EHC. Tidal Investments LLC grew its stake in shares of Encompass Health by 5.7% in the 3rd quarter. Tidal Investments LLC now owns 3,509 shares of the company's stock valued at $339,000 after buying an additional 188 shares in the last quarter. Miracle Mile Advisors LLC boosted its position in Encompass Health by 3.0% during the fourth quarter. Miracle Mile Advisors LLC now owns 3,835 shares of the company's stock worth $354,000 after purchasing an additional 112 shares during the period. Pallas Capital Advisors LLC bought a new stake in Encompass Health during the fourth quarter worth approximately $237,000. Oak Thistle LLC bought a new stake in Encompass Health during the fourth quarter worth approximately $2,099,000. Finally, Park Avenue Securities LLC boosted its position in Encompass Health by 44.7% during the fourth quarter. Park Avenue Securities LLC now owns 6,737 shares of the company's stock worth $622,000 after purchasing an additional 2,082 shares during the period. Institutional investors own 97.25% of the company's stock.

Insider Activity at Encompass Health

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now owns 79,710 shares of the company's stock, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the completion of the transaction, the insider now directly owns 11,958 shares in the company, valued at $1,394,422.38. The trade was a 26.35% decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by company insiders.

Encompass Health Price Performance

Shares of EHC stock traded up $1.17 during trading hours on Friday, hitting $120.94. 904,433 shares of the company's stock were exchanged, compared to its average volume of 693,345. The stock's 50-day moving average is $105.43 and its 200-day moving average is $100.74. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The stock has a market cap of $12.19 billion, a price-to-earnings ratio of 27.12, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. Encompass Health Co. has a 52 week low of $82.74 and a 52 week high of $121.28.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to analysts' expectations of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The firm's quarterly revenue was up 10.6% compared to the same quarter last year. During the same quarter last year, the business earned $1.12 earnings per share. As a group, research analysts forecast that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.17 dividend. This represents a $0.68 annualized dividend and a yield of 0.56%. The ex-dividend date of this dividend is Tuesday, July 1st. Encompass Health's dividend payout ratio is 14.05%.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on EHC. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. UBS Group upped their target price on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a research report on Monday, April 28th. Truist Financial reaffirmed a "buy" rating and set a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Barclays upped their target price on Encompass Health from $118.00 to $129.00 and gave the stock an "overweight" rating in a research report on Friday, April 25th. Finally, KeyCorp upped their price target on Encompass Health from $120.00 to $122.00 and gave the stock an "overweight" rating in a report on Friday, April 25th. Nine equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Encompass Health has a consensus rating of "Buy" and a consensus price target of $120.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.